Source:http://linkedlifedata.com/resource/pubmed/id/12436435
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-11-18
|
| pubmed:abstractText |
To review the biochemical recurrence-free survival (bRFS) rates of treatment with either external beam radiotherapy or radical prostatectomy in patients with biopsy Gleason score 8 or above in the prostate specific antigen (PSA) era.
|
| pubmed:language |
eng
|
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10977
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2302-7
|
| pubmed:dateRevised |
2009-11-3
|
| pubmed:articleTitle |
Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
|
| pubmed:affiliation |
Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, USA. kupelian@orhs.org
|